Buradasınız

Anasayfa » Content

ALZHEIMER HASTALIĞI VE DENTAL YAKLAŞIM.

ALZHEIMER'S DISEASE AND DENTAL MANAGEMENT

Journal Name:

  • İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Alzheimer's disease is a cortical, degenerative, progressive brain disorder that gradually destroys a person's memory and ability to learn, make judgments, communicate and carry out daily activities. Cognitive and motor deficits may led difficulties to perform adequate oral hygiene and communicate discomforts such as pain or dysfunction. To maintain lifelong good oral health in this patients, regular dental care is a necessity. The most critical point is to sepecify the individual treatment needs for Alzheimer's patients. This review summarizes the causes, epidemiology diagnosis, and dental management of Alzheimer's disease.
Bookmark/Search this post with
Abstract (Original Language): 
Alzheimer hastalığı kişinin hafıza, öğrenme, karar verme, iletişim kurma, günlük aktivilelerini yerine getirme gibi yeteneklerinde yavaş ve ilerleyici hasar yaratan kortikal dejeneratif bir beyin hastalığıdır. Bilişsel ve motor fonksiyonlarda meydana gelen bozulma, kişinin yeterli ağız hijyeni uygulamalarını yerme getirmesine, ağrı ya da disfonksiyon gibi rahatsızlıklarını dile getirmesine engel olur. Bu hastalarda yaşam boyu ağız sağlığının devamlılığının sağlanabilmesi için düzenli dental bakım şartiır. Hastalığa sahip bireyler için. her bir bireyin ihtiyaçlarına uygun tedavi seçeneklerini belirlemek son derece hassas ve üzerinde önemle durulması gereken bir konudur. Bu derleme çalışması Alzheimer hastalığının nedenleri, epidemiyolojisi, teşhis ve dental tedavi stratejilerini özetlemektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-alzheimer-hastaligi-dental-yaklasim.pdf
  • 3
31
38
  • Turkish

REFERENCES

References: 

1. Kocaelli H, Yaltirik M,
Yargi
c LI, Ozbas H. Alzheimer's disease and dental management.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 May; 93 (5): 521-4.
2. Gitto CA. Moroni MJ. Terezhalmy GT, Sandu S. The patient with Alzheimer's disease. Quintessence Int. 2001 Mar; 32 (3): 221-31.
3. Doran M. Diagnosis of presenile dementia. Br J Hosp Med." 1997 Jul 9-Aug 19; 58 (2-3): 105-10.
4. www.alz.org
5. http://www.liaf.org/disease.shlml
6. Nordenram G. Ryd-Kjellen E. Ericsson K, Winblad 15. Dental management of Alzheimer
Senem ÖZER. Hümeyra KOCAELLİ, Mehmet YALTİRİK
patients. A predictive test of dental cooperation in individualized treatment planning. Acta Odontol Scand. 1997 Jun; 55 (3): 148-54.
7. Whittle JG, Sarll DW, Grant AA, Worthington IIV. The dental health of the elderly mentally ill: a preliminary report. Br Dent J. 1987 May 23; 162 (10): 381-3.
8. Reiman EM, Caselli RJ. Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996 Mar 21; 334 (12): 752-8.
9. http://ww\v. novartis.com.tr/Sosval Sorumluluk alzheimer iitııuı 2003.asp
10. www.eiirekah.com/chapter/907
11. Reiman EM, Caselli RJ. Alzheimer's disease. Maturitas. 1999 Mar 15; 31 (3): 185-200.
12. w ww .alz.oi Li.lr
13. llendrie HC. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry. 1998 Spring; 6 (2 Suppl 1):S3-18.
14. Hofman A. Ott A, Breteler MM, Bots ML, Slooter A.I. van Harskamp F, van Duijn CN, Van Broeckhoven C. Grobbee DE. Atherosclerosis, apolipoprotein E. and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997 Jan 18; 349 (9046): 151-4.
15. Tang MX, Stern Y. Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L. Tycko B, Mayeux R. The APOE-epsiIon4 allele and the risk of Alzheimer disease among African Americans, whiles, and Hispanics. JAMA. 199S Mar 11; 279(10): 751-5.
16. Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T. Helms Ml. Swift M. Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol. 1983 Nov; 14 (5): 507¬15.
17. Topçuoğlu ES, Selekler K. Alzheimer Hastalığı. Geriatri. 1998; 1 (2): 63-67.
18. Koçer B. Dcmans epidcmiyolojisi. Demans Dizisi. 1999; 1: 41-44.
19. Clarke R. Smith AD. Jobst KA. Reistim II. Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998 Nov; 55 (II): 1449-55.
Alzheimer
Hastalığ
ı ve Denial Yaklaşım
20. Nourhashemi F, Gillette-Guyonnet S, Andrieıı S. Ghisolfı A. Ousset P.I. Grandjean H. Grand A. Pous J. Vellas B, Albarede JL. Alzheimer disease: protective factors. Am J Clin Nutr. 2000 Feb; 71 (2): 643S-649S.
21. Saxe SR, Wekstein MW. Kryscio RJ. Henry RG, Cornell CR. Snowdon DA. Grant FT, Schmitt FA, Donegan Si. Wekstein DR. Ehmann WD. Markesbery WR. Alzheimer's disease, dental amalgam and mercury. J Am Dent Assoc. 1999 Feb; 130(2): 191-9.
22. Ghezzi EM. Ship JA. Dementia and oral health. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Jan; 89 (1): 2-5.
23. Evans DA. Funkenstein HH. Albert MS. Scherr PA. Cook NR. Chown MJ. Hebert LE. Ilennekens CM. Tayloi JO. Prevalence ol .Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989 Nov 10; 262 (18): 2551-6.
24. Geldmacher, D. S. (199S). Office diagnosis and management of Alzheimer's disease. Mediguide to Geriatric Neurology, 2 (4). 1-8.
25. Perl DP. Neuropathology of Alzheimer's disease and related disorders. Neurol Clin. 2000 Nov; 18(4): 847-64.
26. Zapotoczky HG. Problems of differential diagnosis between depressive pscudodementia and Alzheimer's disease. J Neural Transm
• Suppl. 1998; 53: 91-5.
27. Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a IIS Multicentre. Randomized. Double-Blind. Placebo-Controlled Trial. The Donepezil Study Group. Dementia. 1996 Nov-Dec: 7 (6): 293-303.
28. Grundman M. Thai LJ. Treatment of Alzheimer's disease: rationale and strategies. Neurol Clin. 2000 Nov; 18 (4): 807-28.
29. van Reekum R. S i mar d M. Farcnik K. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment. Can Fam Physician. 1999 Apr: 45: 945-52.
30. Sano M; Update on treatment of cognitive symptoms in dementia. In: Dementia Update.
37
American Academy of Neurology 49th Annual Meeting, April 12-19. 1997 Boston, MA; 1997. American Academy of Neurology Press, USA, 1997: 107-115.
31. Sano M et al. A controlled trial of selegiline, alpha-tocophenol, or both as treatment for Alzheimer's disease. N Engl J Med 1997; 336: 1216-1222.
32. Drachman DA. Leber P. Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less. N Engl J Med. 1997 Apr 24; 336 (17): 1245-7. Comment on: N Engl J Med. 1997 Apr 24: 336(17): 1216¬22.
33. Kleijncn J. Knipschild P. Ginkgo biloba. Lancet. 1992 Nov 7; 340 (8828): 1136-9.
34. Le Bars PL. Katz MM. Berman N. Itil I'M. Lrecdman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA.
1997 Oct 22-29; 278 (16): 1327-32. Comment in: ACP J Club. 1998 May-Jun; 12S (3):70.
35. Mintzer JE. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease. J Clin Psychiatry. 2001; 62 Suppl 21: 23-5.
36. www.alzla.org/ireatment/AN-1792.html
37. Knopman DS, Morris JC: An update on primary drug therapies for Alzheimer Disease. Arch Neurol 1997; 54: 1406-1409.
38. Rogers J. Kirby LC. Hcmpelman SR; Clinical (rials of indomethacine in Alzheimer's disease. Neurology 1993:43: 1609-1611.
39. Xu II. Gouras GK. Greenfield .IP. Vincent B. Naslund J. Mazzarelli L. Fried G. Jovanovic JN. Seeger M. Relkin NR. Liao F. Checler F, Buxbaum .ID. Chait BT. Thinakaran (i, Sisodia SS. Wang R. Greengard P. Gaudy S.Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med.
1998 Apr; 4 (4): 447-51.
40. Paganini-IJill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Intern Med. 1996 Oct 2S; 156 I 19): 2213-7.
41. Stewart WF. Kawas C. Corrada M. Metier I-J. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997 Mar; 4S (3). 626-32.
38
42. Nathanson [L. Problems in the care management of the aging patient: legal, financial and practical implications. Pa Dent J (Harrisb). 1999 May-Jun; 66 (3): 19-23.
43. Henry RG. Wekstein DR. Providing dental care for patients diagnosed with Alzheimer's disease. Dent Clin North Am. 1997 Oct; 41 (4): 915-43.
44. Niessen LC. Jones JA. Zocchi M. Gurian B. Dental care for the patient with Alzheimer's disease. J Am Dent Assoc. 1985 Feb; 110 (2): 207-9.
45. Henry RG. Alzheimer's disease and cognitively impaired elderly: providing dental care. J Calif Dent Assoc. 1999 Sep; 27 (9): 709-17.
46. Kieser J, Jones G. Borlase G. MacFadyen E. Dental treatment of patients with neurodegenerative disease. N Z Dent J. 1999 Dec; 95 (422): 130-4.
47. Matear DW, Clarke D. Considerations for the use of oral sedation in the institutionalized geriatric patient during dental interventions: a review of the literature. Spec Care Dentist. 1999 Mar-Apr; 19 (2): 56-63.
48. Carr-Hosie MA. Treatment considerations for the dental professional for patients with Alzheimer's disease. J Okla Dent Assoc. 1993 Winter; 83(3): 36-42.
49. Navazesh M. Mulligan R. Systemic dissemination as a result of oral infection in individuals 50 years of age and older. Spec Care Dentist. 1995 Jan-Feb; 15 (1): 11-9.
Senem ÖZER, Hümcyra KOCAELLİ, Mehmet YALTIR1K
50. Ship JA, DeCarli C, Frıedland RP, Batım BJ. Diminished submandibular salivary flow in dementia of the Alzheimer type. J Gerontol. 1990 Mar; 45(2): M61-6.
51. Ship J A. Oral health of patients with Alzheimer's disease. J Am Dent Assoc. 1992 Jan: 123 (1): 53-8.
52. Jones JA, Lavallee N. Alman J, Sinclair C, Garcia RI. Caries incidence in patients with dementia. Gerodontology. 1993 Dec; 10 (2): 76-82
53. Ocasio NA, Solomowitz BH, Sher MR. Dental management of the patient with Alzheimer's disease. N Y State Dent J. 2000 Mar; 66 (3): 32-5.
54. Barrett-Connor E. Edelstein SL. Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc. 1996 Oct; 44 (10): 1147-52.
55. Whitmyer CC, Terezhalmy GT. Miller DL, Hujer ME. Clinical evaluation of the efficacy and safety of an ultrasonic toothbrush system in an elderly patient population. Geriatr Nurs. 1998 Jan-Feb: 19 (1): 29-33.
56. ADA Oral Health Care Guidelines: Patients with physical and mantal disabilities. Chicago: American Dental Association. 1991.
57. Shimazaki Y. Soh I. Saito T. Yamashita Y. Koga T, Miyazaki II, Takehara T. Influence of dentition status on physical disability, mental impairment, and in institutionalized elderly people. J Dent Res. 2001 Jan; 80 (1): 340-5. Comment in: J Dent Res. 2001 Dec; 80 (12): 2042.

Thank you for copying data from http://www.arastirmax.com